CA9 Antikörper (AA 38-414) (HRP)
Kurzübersicht für CA9 Antikörper (AA 38-414) (HRP) (ABIN7139770)
Target
Alle CA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 38-414
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Peptide sequence from Human Carbonic anhydrase 9 protein (38-414AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - CA9 (Carbonic Anhydrase IX (CA9))
- 
                                            Andere Bezeichnung
- CA9
- 
                                            Hintergrund
- 
                        Background: Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia. Aliases: CA-IX antibody, CA9 antibody, CAH9_HUMAN antibody, CAIX antibody, Carbonate dehydratase IX antibody, Carbonic anhydrase 9 antibody, Carbonic anhydrase IX antibody, Carbonic dehydratase antibody, G250 antibody, Membrane antigen MN antibody, MN antibody, P54/58N antibody, pMW1 antibody, RCC associated protein G250 antibody, RCC-associated antigen G250 antibody, Renal cell carcinoma-associated antigen G250 antibody 
- 
                                            UniProt
- Q16790
 Target
- 
                    
 
                                     
                                     
                                    